We are live on ! Find out more
WVE icon

Wave Life Sciences
WVE

46 hedge funds and large institutions have $456M invested in Wave Life Sciences in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

80% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 10

55% more capital invested

Capital invested by funds: $294M → $456M (+$162M)

18% more funds holding

Funds holding: 39 → 46 (+7)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
46
Holders Change
+7
Holders Change %
+17.95%
% of All Funds
1.23%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
9
Increased
18
Reduced
10
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PA
Perceptive Advisors
New York
+$3.8M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$3.36M
3
CAM
Cormorant Asset Management
Massachusetts
+$2.68M
4
Jennison Associates
Jennison Associates
New York
+$1.78M
5
Northern Trust
Northern Trust
Illinois
+$1.37M

Top Sellers

1
RG
Redmile Group
California
-$9.3M
2
FCMI
Foresite Capital Management III
California
-$5.73M
3
Goldman Sachs
Goldman Sachs
New York
-$931K
4
Deutsche Bank
Deutsche Bank
Germany
-$757K
5
Renaissance Technologies
Renaissance Technologies
New York
-$739K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$230M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$60.5M +$47.3K +2,000 +0.1%
NLVP
3
New Leaf Venture Partners
New York
$25.5M – – –
FCMI
4
Foresite Capital Management III
California
$23.6M -$5.73M -242,608 -25%
RG
5
Redmile Group
California
$22.8M -$9.3M -393,651 -36%
PA
6
Perceptive Advisors
New York
$22.2M +$3.8M +160,853 +31%
CAM
7
Cormorant Asset Management
Massachusetts
$16.5M +$2.68M +113,500 +29%
EAM
8
Eventide Asset Management
Massachusetts
$12.3M – – –
CCP
9
Clough Capital Partners
Massachusetts
$8.02M -$379K -16,047 -6%
BFA
10
BlackRock Fund Advisors
California
$6.61M +$256K +10,835 +6%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$4.62M +$3.36M +142,320 New
Vanguard Group
12
Vanguard Group
Pennsylvania
$3.97M +$102K +4,337 +4%
State Street
13
State Street
Massachusetts
$3.34M +$426K +18,040 +21%
Northern Trust
14
Northern Trust
Illinois
$2.97M +$1.37M +58,088 +174%
Jennison Associates
15
Jennison Associates
New York
$2.45M +$1.78M +75,435 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$2.18M +$173K +7,309 +12%
BIT
17
BlackRock Institutional Trust
California
$1.86M +$31.8K +1,346 +2%
BIM
18
BlackRock Investment Management
Delaware
$908K -$945 -40 -0.1%
Charles Schwab
19
Charles Schwab
California
$702K +$22.5K +952 +5%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$693K +$64.2K +2,718 +15%
VIA
21
Vident Investment Advisory
Georgia
$628K -$307K -12,990 -40%
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$510K +$4.73K +200 +1%
TA
23
Teachers Advisors
New York
$386K – – –
MC
24
Matisse Capital
Oregon
$334K +$243K +10,296 New
RhumbLine Advisers
25
RhumbLine Advisers
Massachusetts
$255K +$186K +7,862 New
1
2

WVE Hedge Fund Activity: Q3 2016 in Review

46 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q3 2016, worth a combined $456M — up 55% from $294M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new WVE positions and 2 closed out — a net gain of 7 holders — while 18 added to existing stakes and 10 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $3.8M. The largest seller was Redmile Group, cutting an estimated $9.3M.

  • 46 institutional investors held Wave Life Sciences (WVE) as of Q3 2016, up from 39 in Q2 2016.
  • Funds reported $456M of Wave Life Sciences stock for Q3 2016, up 55% quarter-over-quarter.
  • 9 funds opened new Wave Life Sciences positions in Q3 2016 and 2 closed out, a net change of +7 holders.
  • The largest Wave Life Sciences buyer in Q3 2016 was Perceptive Advisors, an estimated $3.8M added.
  • The largest Wave Life Sciences seller in Q3 2016 was Redmile Group, an estimated $9.3M sold.

Based on aggregated 13F filings for Q3 2016.